• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
EconomyTariffs and trade

U.S. trade deficit widens to a record on pre-tariff drug imports

By
Mark Niquette
Mark Niquette
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Mark Niquette
Mark Niquette
and
Bloomberg
Bloomberg
Down Arrow Button Icon
May 6, 2025, 11:37 AM ET
Shipping containers in port of Los Angeles
Shipping containers stacked up in port in Los Angeles. The trade deficit in March widened to a record as shippers rushed to get imports in ahead of tariffs.I RYU/VCG via Getty Images

The U.S. trade deficit widened to a record in March as companies rushed to import products including pharmaceuticals as the Trump administration readied sweeping tariffs.

Recommended Video

The goods and services trade gap grew 14% from the prior month to $140.5 billion, Commerce Department data showed Tuesday. The median estimate in a Bloomberg survey of economists was for a $137.2 billion deficit.

Imports of consumer goods climbed by the most on record, primarily due to the largest-ever inflow of pharmaceutical preparations. Imports of capital equipment and motor vehicles also increased.

The report illustrates what was likely the final push by U.S. companies to secure goods before President Donald Trump announced expansive duties on April 2. While drug imports were excluded, the president has said a decision on pharmaceutical tariffs will be made in the coming weeks.

The March surge in imports of pharmaceutical preparations propelled the goods-trade deficit with Ireland, a major source of those components, to $29.3 billion, more than doubling from the previous month. That surpassed the shortfall with China, on a seasonally adjusted basis.

The dramatic widening of the trade deficit in the first quarter was the key reason the economy contracted for the first time since 2022. Gross domestic product fell an annualized 0.3% in the January-March period, with net exports subtracting nearly 5 percentage points — the most on record.

The value of all imports to the US jumped 4.4% to a record, while exports edged up just 0.2%.

However, Bloomberg Economics sees the import surge from tariff front-running easing, based on a drop in container shipping from China to the US since April 16. As the trade deficit narrows, it will probably support a near-term rebound in economic growth.

Survey data from the Institute for Supply Management showing declining imports by manufacturers and services providers also suggest the strategy of rushing in imports ahead of tariffs is drawing to a close.

Trump is seeking fairness in bilateral commerce, with the aim of encouraging foreign investment in the US, bolstering domestic production and shoring up national industrial security. He also see duties as a means to raise revenue for the government.

The March report showed the goods-trade deficit with Ireland surged to $29.3 billion on a seasonally adjusted basis. US drug companies, including Eli Lilly & Co. and Pfizer Inc., operate nearly two dozen factories in Ireland that ship to the US, according to a TD Cowen analysis. US imports of pharmaceutical preparations jumped 71% in March to a record $50.4 billion.

The shortfall with Canada narrowed, while the deficit with Mexico remained near the record reached in February. The goods-trade deficit with China shrank.

On an inflation-adjusted basis, the total US merchandise trade deficit widened to a record $150.9 billion in March.

Fortune Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Fortune Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Authors
By Mark Niquette
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.